KATHRYN COURTNEY: Open Payments
NPI 1396473914 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,078 in 84 payments from 19 companies in 2025. Trend: 2023 $886 · 2024 $1,097 · 2025 $2,078
Food & beverage: $2,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $420 |
| Ardelyx, Inc. | 11 | $285 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $247 |
| Novo Nordisk Inc | 3 | $193 |
| Regeneron Healthcare Solutions, Inc. | 2 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $140 |
| Aimmune Therapeutics, Inc. | 8 | $139 |
| GENZYME CORPORATION | 4 | $87 |
| Janssen Biotech, Inc. | 3 | $85 |
| Madrigal Pharmaceuticals | 3 | $83 |
Products named: IBSRELA, XIFAXAN, DUPIXENT, RINVOQ, Wegovy, ZENPEP, ENTYVIO, TREMFYA.
Industry payments across NC — which companies pay providers there.
